Picture of Annexin Pharmaceuticals AB (publ) logo

ANNX Annexin Pharmaceuticals AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Annexin Receives German Approval For ANXV Clinical Trial

May 11 (Reuters) - Annexin Pharmaceuticals AB (publ) ANNX.ST:

RECEIVES GERMAN APPROVAL FOR ANXV CLINICAL TRIAL

NEXUS PHASE 2A STUDY TO EXPAND TO GERMANY FOR RVO AND DR

Source text: ID:nMFNQw4Zn

Further company coverage: ANNX.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Annexin Pharmaceuticals AB (publ)

See all news